Table 2.
The minimum inhibitory concentration and susceptibility of C. arthrosphaerae ED882-96.
| Antibiotic Group | Antibiotics | MIC | Interpretation |
|---|---|---|---|
| β-lactams, β-lactam/β-lactamase inhibitors | Piperacillin | >64 | R |
| Piperacillin-tazobactam | >128/4 | R | |
| Ticarcillin-clavulanic acid | >64/2 | R | |
| Ceftazidime | >16 | R | |
| Cefepime | >32 | R | |
| Ceftriaxone | >32 | R | |
| Aztreonam | >16 | R | |
| Imipenem | >8 | R | |
| Meropenem | >8 | R | |
| Aminoglycosides | Gentamicin | >8 | R |
| Tobramycin | >8 | R | |
| Amikacin | >32 | R | |
| Tetracyclines/glycylcycline | Tetracycline | >8 | R |
| Minocycline | >8 | R | |
| Tigecycline | >8 | R | |
| Fluoroquinolones | Ciprofloxacin | >2 | R |
| Levofloxacin | >8 | R | |
| Folate pathway inhibitors | Trimethoprim-sulfamethoxazole | >4/76 | R |
MIC, minimum inhibitory concentration.